American Trust Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,960
Closed -$232K 86
2021
Q1
$232K Sell
1,960
-1,545
-44% -$181K 0.14% 74
2020
Q4
$411K Hold
3,505
0.25% 52
2020
Q3
$364K Sell
3,505
-10
-0.3% -$1K 0.26% 50
2020
Q2
$322K Buy
3,515
+30
+0.9% +$2.88K 0.26% 43
2020
Q1
$314K Buy
+3,485
New +$371K 0.32% 43

Other funds holding MDT

American Trust Investment Advisors's MDT Position: Q2 2021 in Review

American Trust Investment Advisors sold out of Medtronic (MDT) in Q2 2021, closing a stake of 1,960 shares — an estimated $232K sold.

American Trust Investment Advisors first reported a position in MDT in Q1 2020 and held it in 5 quarters. The position peaked at $411K in Q4 2020. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • American Trust Investment Advisors reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
  • American Trust Investment Advisors sold 1,960 Medtronic shares in Q2 2021, an estimated $232K.
  • American Trust Investment Advisors first reported a position in Medtronic in Q1 2020 and held it in 5 quarters.
  • American Trust Investment Advisors's Medtronic position peaked at $411K in Q4 2020.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on American Trust Investment Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.